What to Expect at the 4th LNP Characterization & Analytical Development Summit
Join the only summit dedicated exclusively to advancing LNP characterization and analytical development for RNA and genetic medicines. Across two days of technical presentations, interactive discussions, poster sessions, and networking, connect with leaders in analytical development, characterization, formulation, and CMC to tackle the industry’s biggest challenges. Discover the latest approaches to predictive CQAs, advanced structural analytics, targeted LNPs, and complex payload systems, and leave with practical insights to accelerate development and strengthen product understanding.
Event Highlights:
Define the Right Critical Quality Attributes (CQAs) for Next-Generation LNPs
Join Amplitude, Stylus & Beam Therapeutics to move beyond traditional characterization metrics, learn how to identify and measure the CQAs that truly influence potency, stability, efficacy, and regulatory success
Strengthen Analytical Strategies Across the Entire Development Lifecycle
Gain practical approaches to improve characterization from early discovery through process development, comparability, scaleup, tech transfer, and commercial readiness with Merck, ModeX & Novo Nordisk
Unlock Deeper Insight Into LNP Structure, Heterogeneity & Performance
Explore advanced analytical technologies, including cryo-EM, mass spectrometry, SAXS, and multiattribute methods, to better understand structure function relationships and reduce development risk with Strand & Genetech
Stay Ahead of Emerging Challenges in Targeted & Multi- Cargo LNP Systems
Learn how Tessera, Prime Medicine & Granza Bio are solving the growing analytical complexity introduced by targeted delivery platforms, novel lipid systems, and increasingly sophisticated payload combinations
Benchmark with the Industry’s Leading Analytical & Characterization Experts
Connect with peers from AbbVie & Sanofi across analytical development, characterization, formulation, and CMC to exchange practical lessons, compare approaches, and accelerate decisionmaking with realworld insight
What's New for 2026?
New Focus on Predictive CQAs
Move beyond traditional particle measurements and explore how predictive analytical strategies can better connect product attributes to biological outcomes.
Greater Emphasis on Targeted LNP Analytics
Dive deeper into ligand conjugation, surface characterization, and analytical approaches for next-generation targeted delivery platforms.
Expanded Coverage of Complex Payload Systems
New sessions dedicated to trans-amplifying RNA, multi-cargo characterization, and analytical strategies supporting advanced genetic medicines.
New Perspectives from Emerging Innovators
Hear fresh insights from companies advancing analytical development across targeted delivery, gene editing, in vivo applications, and novel RNA modalities.
Attending Companies Include